Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Risedronate for the Primary and Secondary Prevention of Osteoporotic Fractures in Postmenopausal Women." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436140/all/images/. Accessed 11 May 2024.
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436140/all/images/. Accessed May 11, 2024.
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436140/all/images/
Risedronate for the Primary and Secondary Prevention of Osteoporotic Fractures in Postmenopausal Women [Internet]. In: Cochrane Abstracts. [cited 2024 May 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436140/all/images/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
ID - 436140
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436140/all/images/
DB - Evidence Central
DP - Unbound Medicine
ER -